Concepedia

Rebecca Leyland

RL

Statistics

Publications

10

Citations

965

H-Index

10

Active since

2008

Affiliations

Babraham Institute(Current)

Altimmune (United States)

Rebecca Leyland is an author at Babraham Institute specializing in immunology, medicine, and life sciences.

Publications per year

2008–2021

10

Publications

10

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson et al. · Cancer Immunology Research · 2016 · 423 citations

Medicine, Immunology, Oncology +16

MicroRNA-155 Is Required for <i>Mycobacterium bovis</i> BCG-Mediated Apoptosis of Macrophages

Devram Sampat Ghorpade, Rebecca Leyland, Mariola Kurowska‐Stolarska et al. · Molecular and Cellular Biology · 2012 · 135 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation

Dong Lu, Rinako Nakagawa, Sandra Lazzaro et al. · The Journal of Experimental Medicine · 2014 · 91 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Characterisation of 5‐HT<sub>3C</sub>, 5‐HT<sub>3D</sub>and 5‐HT<sub>3E</sub>receptor subunits: evolution, distribution and function

Joanna D. Holbrook, Catherine H. Gill, Noureddine Zebda et al. · Journal of Neurochemistry · 2008 · 81 citations

Life Sciences, Neurobiology, Neuroscience +17

Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

Geoffrey S. Williams, Sandrine Guillard, Jane Coates Ulrichsen et al. · Oncotarget · 2016 · 57 citations · Full text

Medicine, Immunology, Oncology +7

1–5 of 10